About this trial
The objective of this study is to investigate safety and performance of the Free Margin Cusp sizer. The device will be used during aortic valve repair and sparing procedures as a caliper to measure the aortic valve free margin length at different stages of the procedure. The patient will be followed for one year clinically (at 1, 2, 6 and 12 months) and by echocardiography (at 6 and 12 months) to assess aortic valve function.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients with Tricuspid Aortic Valve (TAV) operated electively for aortic valve regurgitation and or ascending aorta dilatation.
Disqualifiers
Acute aortic dissection;
Diffuse aortic valve calcification;
AV endocarditis;
Bicuspid, unicuspid or quadricuspid aortic valves;
Trial design
Single group
Treatments tested in this trial
Free Margin Cusp Sizer
DeviceThe free margin cusp sizer will be used during aortic valve repair and sparing procedures as a caliper to measure the aortic valve free margin length.
Treatment groups
Trial outcomes
Primary outcomes
Intraoperative aortic valve (AV) damage
Aortic valve damage caused by the cusp sizer (cusp tear or perforation), rate of conversion from AV repair to AV replacement due to the use of the cusp sizer
Hospital mortality
Patient Survival status at 30 days after surgery
Major adverse cardiac and cerebrovascular events (MACCE)
Mortality, stroke or transient ischemic attack, major bleeding, cardiac reintervention
Aortic valve function
Aortic valve regurgitation and transvalvular gradient by transthoracic echocardiography
Secondary outcomes
Pre-repair free margin length
Length of the 3 leaflets free margin before aortic valve repair
Sponsors and contacts
Click on the lead sponsor to view all of their trials.